Lebanon has recorded its first case of the often-fatal Middle East respiratory virus, the Health Ministry said Friday.
The virus was detected Thursday in a man who had checked into a local hospital after feeling ill, the ministry said. It said the case was not severe, and the man has since been discharged.
A ministry official said the patient had recently returned from a visit to several Gulf countries, including Saudi Arabia.
The kingdom has been the focal point of the outbreak of the virus, known as the Middle East Respiratory Syndrome.
MERS belongs to a family of viruses that include both the common cold and SARS, which killed some 800 people in a global outbreak in 2003. It can cause symptoms that include fever, breathing problems, pneumonia and kidney failure.
Not everyone who contracts the virus that causes MERS gets sick, while others show only mild symptoms. There is no cure or vaccine.
Still, the threat from the virus has prompted health officials around the region to adopt protective measures to try to prevent the spread of the disease.
In Lebanon, the health minister on Thursday ordered that thermal cameras be set up at Beirut's international airport to check arriving passengers for possible signs of fever, indicating a possible MERS infection.
Five more people have died in Saudi Arabia after contracting an often fatal Middle East respiratory virus as the number of new infections in the kingdom climbs higher, health officials confirmed Thursday.
An international research team led by the University of Pittsburgh Graduate School of Public Health has shown that epidemics of dengue, which is caused by a mosquito-borne virus, across southeast Asia appear to be linked ...
Researchers from the University of Zurich and the University Hospital Zurich reveal possible new treatment methods for a rare, usually fatal brain disease. Thanks to their discovery that specific antibodies play a key role ...
(Medical Xpress)—Chloroquine (CQ) is a first-line treatment for Plasmodium falciparum infections, which like many other malaria treatments, eventually resulted in the selection of parasites with resistance to the drug. ...
Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...
Please sign in to add a comment.
Registration is free, and takes less than a minute.
Click here to reset your password.
Sign in to get notified via email when new comments are made.